LicianPro

CAMP stock

CAMP4 THERAPEUTICS CORPORATION (CAMP) short interest & short volume · 3.5M shares short

CAMP4 THERAPEUTICS CORPORATION official short interest (FINRA, twice monthly) and daily short volume (FINRA Reg SHO), with history, % of float and days to cover.

What changed

CAMP short interest rose 136.4% to 3.5M shares in the Oct 15, 2026 report (10.1 days to cover). Daily short volume averaged 61.1% of volume over the last 20 sessions, down from 64.0% the 20 sessions before, the 87th percentile of its own 20-day averages since Sep 23, 2025.

Short interest

Official, twice monthly · settled Oct 15, 2026

Shares short
3.5M
prior 1.5M
% of float
—
no float on file
Days to cover
10.1
avg vol 343K
Change vs prior report
+136.4%

6 reports

The last 24 reports (about a year) with Lician Pro.Start 3-day trial — $149/yr

Days to cover is short interest divided by FINRA's average daily volume for the period: how many average days of trading it would take shorts to buy back.

Source: FINRA equity short interest (twice monthly) · Settlement Oct 15, 2026

Daily short volume

Share of each day's volume sold short · FINRA Reg SHO

Latest (Nov 2)
45.2%
17K of 38K
20-day average
61.1%
prior 64.0%
Percentile vs own history
87th
233 periods since 2025

Loading prices…

Short volumeRest of the day's volume

Source: FINRA Reg SHO daily short sale volume · Latest Nov 2, 2026

Short squeeze score (model)

Price since settlement: +11.0%

Model, not a forecast: 40 pts short interest % of float (full at 30%), 25 pts days to cover (full at 10), 15 pts rise in short interest since the prior report (full at +50%), 20 pts price gain since the settlement date (full at +25%). Missing inputs score 0.

CAMP's squeeze score and its inputs with Lician Pro.Start 3-day trial — $149/yr

Market-wide: most shorted stocks, biggest changes and unusual short volume · CAMP overview

Last 10 sessions · daily short volume · FINRA Reg SHO
DateShortTotalShort % of volume
2026-11-0217,18938,04145.2%
2026-10-3019,85636,30854.7%
2026-10-2924,15242,70856.5%
2026-10-2812,44432,18338.7%
2026-10-2744,85989,64250.0%
2026-10-2613,36422,75358.7%
2026-10-2318,486223,4288.3%
2026-10-2226,40753,69549.2%
2026-10-2133,10395,45634.7%
2026-10-2017,11621,64379.1%

Healthcare peers with similar quant ratings

CAMP is rated 1.15 of 5 among 532 rated Healthcare stocks (Lician quant rating, Nov 4, 2026). How the rating works

CAMP short interest FAQ

What is CAMP's short interest?

CAMP4 THERAPEUTICS CORPORATION (CAMP) had 3.5M shares sold short and not yet covered in FINRA's Oct 15, 2026 settlement report.

How many days to cover does CAMP have?

10.1 days: 3.5M shares short divided by an average daily volume of 343K for the Oct 15, 2026 period.

Is CAMP short interest rising or falling?

CAMP short interest rose (+136.4%) from 1.5M to 3.5M shares in the Oct 15, 2026 report.

Is CAMP a short squeeze candidate?

Lician's squeeze watch scores CAMP 49 out of 100 (elevated) from the Oct 15, 2026 report: days to cover 25/25, change in short interest vs prior report 15/15, price change since settlement date 8.8/20. It is a transparent model of how crowded the short side is, not a forecast that a squeeze will happen.

What share of CAMP daily volume is sold short?

61.1% on average over the last 20 sessions to Nov 2, 2026 (FINRA Reg SHO daily short volume; the 87th percentile of its own 20-day averages). Short volume counts market makers' same-day short sales, so it is not short interest.

What was CAMP's latest FINRA short volume?

On Nov 2, 2026, cached FINRA short volume for CAMP4 THERAPEUTICS CORPORATION (CAMP) was 17,189 shares, 45.2% of 38,041 total volume.

How many CAMP short-volume sessions are listed on this page?

This page lists 10 cached FINRA short-volume sessions for CAMP4 THERAPEUTICS CORPORATION (CAMP), from Oct 20, 2026 through Nov 2, 2026.

How did CAMP short volume percent change from the prior cached session?

Cached FINRA short volume for CAMP4 THERAPEUTICS CORPORATION (CAMP) moved from 54.7% on Oct 30, 2026 to 45.2% on Nov 2, 2026, down 9.5 percentage points.

Not investment advice. Figures as filed or reported, not a live feed.